{"id":45531,"date":"2023-11-20T05:19:07","date_gmt":"2023-11-20T11:19:07","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/gbm-mr-ner-outcomes-data\/"},"modified":"2023-11-20T05:19:07","modified_gmt":"2023-11-20T11:19:07","slug":"gbm-mr-ner-outcomes-data","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/gbm-mr-ner-outcomes-data\/","title":{"rendered":"GBM-MR-NER-OUTCOMES-DATA"},"template":"","class_list":["post-45531","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Data Citation","tcia_citation_text":"<p>Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J, Freymann J, Jaffe CC, Mikkelsen T, and Flanders A. (2014). <strong>Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor.<\/strong> The Cancer Imaging Archive. <a href=\"https:\/\/doi.org\/10.7937\/K9\/TCIA.2014.FAB7YRPZ\">https:\/\/doi.org\/10.7937\/K9\/TCIA.2014.FAB7YRPZ<\/a><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.7937\/K9\/TCIA.2014.FAB7YRPZ","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/45531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=45531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}